AN

Aleemkhan Nisarudeen

Active Director Director DIN 08607346
DIN 08607346 First appointment Nov 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Aleemkhan Nisarudeen

Data last updated:

Aleemkhan Nisarudeen is a Director at Remedex Pharma Private Limited (since 2019). The company operates in Healthcare. Remedex Pharma Private Limited reported revenue of ₹11.44 Cr (FY 2025).

DIN 08607346
Primary Designation Director
Industry Healthcare
First Appointment 13 Nov 2019
Oldest Company Age 9 yrs
Largest company Remedex Pharma Private Limited · ₹11.44 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Remedex Pharma Private Limited U74999KL2016PTC047213
Director13 Nov 20192016₹11.44 Cr (FY 2025)Active

Board colleagues of Aleemkhan Nisarudeen

Directorship timeline

Open interactive timeline →
Remedex Pharma Private Limited
Premium access

Shareholding and investment profile for Aleemkhan Nisarudeen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aleemkhan Nisarudeen

Aleemkhan Nisarudeen currently holds 1 directorship: Remedex Pharma Private Limited (Director, since 13 Nov 2019, revenue ₹11.44 Cr (FY 2025)).

Aleemkhan Nisarudeen was first appointed on 13 Nov 2019 as Director at Remedex Pharma Private Limited.

The current boards of Aleemkhan Nisarudeen's companies include Salman Mohammed Siddikh (Remedex Pharma Private Limited), Shibin Lal Babu Kamalabai (Remedex Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available